RxDoctor Payments Data

Holly Huynh

Physician Assistant · Coppell, TXNPI 1437769544

Payments from drug & device makers

$4,097in general payments, 2019–2025

Across 149 payments — averaging $27.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceutical Holding Company Ltd.$2K
  • AbbVie$574
  • GSK$270
  • Pfizer$256
  • Lilly USA, LLC$243
  • Astellas Pharma US Inc$165
  • plus $1K from 21 others

What the payments were for

  • Consulting fees$80020%
  • Travel & lodging$3047%
  • Food & beverage$2,92671%
  • Education$662%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,097 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin12$18,418
FarxigaDapagliflozin Propanediol12$15,743
Atorvastatin Calcium82$517
Levothyroxine Sodium36$494
Rosuvastatin Calcium57$375
Lisinopril43$360
Omeprazole19$326
Alendronate Sodium40$289
Amlodipine Besylate60$284
Fluticasone Propionate30$272
Sertraline Hcl18$262
Vitamin D2Ergocalciferol (Vitamin D2)17$243
Levocetirizine Dihydrochloride26$224
Losartan Potassium32$217
Pantoprazole Sodium23$180

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$71$18,41812 claims
AstraZenecaFarxiga$69$15,74312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Coppell

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →